Press Releases

Month Year

Feb 5, 2009

Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus® and Rapid-Acting Insulin Apidra®

Team Type 1 Expands Its Roster, Fielding Five Teams to Spread Personal Messages of Successful Diabetes Management to People Living with Type 1 and Type 2 Diabetes
Feb 3, 2009

New Diabetes Resource Provides Tools and Support to Families of Newly-Diagnosed Children with Type 1 Diabetes

"KidCare Kit" offers quick-reference materials and multimedia tools to guide families through the first 30 days following a child's diagnosis
Jan 29, 2009

Alliance of Experts Created to Help Raise Awareness of Best Practices in Diabetes Treatment

Sanofi-aventis U.S. Establishes 'Diabetes National Alliance' of Healthcare Professionals to Help Meet Needs of Growing Diabetes Epidemic in U.S.
Jan 22, 2009

Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care

The Sanofi-Aventis U.S. Community Health Partnership - It's In Our Hands - Has Been Designed To Help Improve Patient Care By Connecting Patients And Caregivers To Healthcare Resources And Services In Local Communities
Dec 15, 2008

Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
Dec 11, 2008

Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care

The Sanofi-Aventis U.S. Community Health Partnership - It’s In Our Hands - Has Been Designed To Help Improve Patient Care By Connecting Patients And Caregivers To Healthcare Resources And Services In Local Communities
Dec 1, 2008

Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured
Nov 11, 2008

Dronedarone (Multaq®) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation

New post-hoc analysis from Athena Study showed that Multaq® on top of standard therapy significantly decreased the total number of hospital days by 28% in patients with atrial fibrillation or flutter
Oct 31, 2008

Third-Quarter 2008 Results
Oct 29, 2008

FDA Approves Rapid-Acting Insulin Apidra® for Treatment of Children with Diabetes

Show per page

Print
Email page
RSS